Background
Methods
Results
CANTAM (http://www.cantam.org)
A1. Project management
NoE (Project Coordinator) # of institutions | Country | Institution | Disease | Focal Person/PI | ||
---|---|---|---|---|---|---|
HIV/AIDS | TB | Malaria | ||||
CANTAM (Francine Ntoumi) 7 | Cameroon | Centre International de Référence Chantal Biya (CIRCB) | X | Odile Ouwe Missi Oukem-Boyer | ||
University of Yaoundé I | X | X | Rose Leke, Veronique Penlap | |||
University of Buea | X | X | Eric Achidi, Peter Ndumbe | |||
OCEAC | X | Parfait Awono | ||||
Congo | University Marien Ngouabi | X | X | X | Francine Ntoumi, Obengui | |
CERVE | X | X | Mathieu Ndounga | |||
Gabon | Medical Research Unit of the Albert Schweitzer Hospital | X | X | X | Saadou Issoufou | |
EACCR (Pontiano Kaleebu) 34 (represented here by 17 leading institutions | Sudan | Institute of Endemic Diseases (IEND), University of Khartoum | X | X | Mukhtar Maowia | |
Ethiopia | Armauer Hansen Research Institute (AHRI) | X | X | Abraham Aseffa | ||
Uganda | Uganda Virus Research Institute (UVRI) | X | Edward Katongole-Mbidde, Jonathan Kayondo, Emily Nyanzi | |||
Medical Research Council (MRC) Unit on AIDS in Uganda | X | Alison Elliott, Heiner Grosskurth | ||||
Makerere University and Infectious Disease Institute | X | X | Elly Katabira, Andrew Kambugu | |||
Kenya | Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Program | X | Norbert Peshu, Peninah Soipei Menza | |||
Kenya Medical Research Institute (KEMRI)-Walter-Reed Project | X | X | Bernhards Ogutu | |||
Kenya Medical Research Institute (KEMRI)-Centre for Global Health Research in partnership with CDC | X | X | X | Kayla Laserson | ||
Kenya AIDS Vaccine Initiative (KAVI)/University of Nairobi | X | X | Walter Jaoko, Omu Anzala | |||
Maseno University | X | Ayub Ofulla | ||||
Tanzania | Kilimanjaro Christian Medical Centre (KCMC)/Kilimanjaro Clinical Research Institute (KCRI) | X | X | X | Gibson Kibiki, Frank Mosha, Reginald Kavishe | |
Ifakara Health Institute (IHI) | X | X | X | Salim Abdulla, Seif Shekaleghe, Salim Nahya | ||
National Institute for Medical Research (NIMR)-Mwanza | X | John Changalucha, Mark Urassa | ||||
National Institute for Medical Research (NIMR)-Tanga Research Centre | X | Martha Lemnge | ||||
National Institute for Medical Research (NIMR)-Mbeya Medical Research Programme | X | X | Leonard Maboko, Lucas Maganga | |||
Muhimbili University of Health and Allied Sciences | X | X | X | Eligius Rwamuya, Joyce Masalu | ||
National Institute for Medical Research (NIMR) -Muhimbili | X | X | Mwele Malecera, Sayoki Mfinanga, Bernard Ngowi | |||
TESA (Alexander Pym) 10 | Botswana | Botswana Harvard HIV/AIDS Partnership (BHP) | X | X | Rosemary Musonda | |
South Africa | South African Medical Research Council: Tuberculosis Research Unit (TBRU) | X | X | Alexander Pym | ||
Stellenbosch University Immunology Research Group (SUN-IRG) | X | X | Gerhard Walzl | |||
University of Cape-Town Lung Institute (UCT-LUNG) | X | Keertan Dheda | ||||
University of Cape Town- Division of Clinical Pharmacology (UCT-PHARM) | X | X | Helen McIlleron | |||
Zimbabwe | University of Zimbabwe College of Health Sciences (UZ-CHS) | X | Lynn Zijenah | |||
Biomedical Research and Training Institute (BRTI) | X | X | Peter Mason | |||
Zambia | University of Zambia –University Teaching Hospital (UN-ZAM) | X | X | X | Peter Mwaba, Duncan Chanda | |
Malawi | Malawi College of Medicine (Malawi- CoM) | X | X | Newton Kumwenda | ||
Mozambique | Centro de Investigacao em Saude da Manhica (CISM) | X | X | X | Eucebio Macete | |
WANETAM (Souleymane Mboup) 13 | Senegal | Laboratory of Bacteriology-virology, A. Le Dantec Hospital (UCAD) | X | X | Souleymane Mboup | |
Institut Pasteur, Dakar | X | Aissatou Toure | ||||
The Gambia | National Public Health Laboratories | X | Makei Taal | |||
Medical Research Council, Fajara The Gambia | X | X | X | Tumani Corrah/Martin Antonio | ||
Guinea Bissau | Project de Saude de Bandim | X | Paulo Rabna | |||
Nigeria | College of Medicine University of Ibadan | X | Aderemi Kehinde | |||
Nigerian Institute of Medical Research | X | Oni Idigbe | ||||
Innovative Biotech | X | Simon Agwale | ||||
Ghana | Korle-bu Teaching Hospital University of Ghana Medical School | X | Audrey Forson | |||
Noguchi Memorial Institute for Medical Research | X | Kwado Koram/Nancy Duah | ||||
Mali | Malaria Research and Training Center, Faculty of Medicine Bamako | X | Ogobara Doumbo/Mahamadou Thera | |||
Burkina Faso | Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou | X | Sodiomon Sirima/ Issa Nebie | |||
Centre Muraz | X | X | Jean B Ouedraogo/ Nicolas Meda |
A2. Baseline studies
A3. Capacity building
NoE | Type of training (number of participants are listed) | Funds (€) leveraged | Number of publications # | Number of sites upgraded | |||||
---|---|---|---|---|---|---|---|---|---|
Short term* | Diploma/BSc | MSc | PhD | Post Doc | Fellowship** | - | - | - | |
CANTAM | 83 | - | 6 | 8 | - | 4 | 1,152,360 | 8 | 4 |
EACCR | 169 | - | 24 | - | - | 4 | 1,400,000 | 1 | 19 |
TESA | 539 | 3 | 12 | 5 | 3 | 2 | 20,000,000 | 29 | 10 |
WANETAM | 175 | - | 2 | 1 | - | 2 | 1,706,000 | 0 | 3 |
Total
|
966
|
3
|
44
|
14
|
3
|
12
|
24,258,360
|
38
|
36
|
A4. Networking
A5. Advocacy
A6. Funding
EACCR (http://www.eaccr.org)
B1. Project management
B2. Baseline studies
B3. Capacity building
Short-term training
Long-term training
Reciprocal clinical monitoring scheme
B4. Networking
B5. Advocacy
B6. Funding
TESA (http://www.tesafrica.org)
C1. Project management
C2. Baseline studies
-
Changes in plasma cytokine levels over time during chronic asymptomatic HIV-1c Infection, an indicator of disease progression
-
HIV-1 incidence rate among patients with sexually transmitted infections
-
Diagnostic and biomarker studies in those patients with suspected TB
-
Epidemiological, microbiological, clinical and socio-economic studies of re-treated TB patients
-
Intensive case finding to determine the prevalence of drug sensitive and resistant-TB among those patients with suspected TB
-
Studies about the burgeoning drug-resistant TB epidemic and therapeutically destitute cases of drug resistant TB